The Warrior Wall honours every sickle cell beneficiary supported by OOSCF — real people, real stories, real impact. Your donation keeps the fight alive.
Healthcare Partners
Organisations we work with
Every number represents a life touched, a family supported, and a future secured through your generosity.
Track our progress and help us hit our quarterly and annual milestones.
Every contribution moves us closer to our quarterly goal.
Hover or tap a card to reveal full warrior details. Click Donate to support a specific warrior.
Showing 0 warriors out of 480+ registered warriors Full list available on request Live Registry 2026
The complete OOSCF Warrior Registry contains over 480 registered beneficiaries. Submit this form to receive a curated list filtered to your criteria — for research, partnership, reporting, or advocacy purposes.
Thank you. Our team will review your request and send the filtered warrior list to your email within 48 hours. For urgent requests, contact info@ooscf.com.
Nominator / Company Details
Warrior Details
From health insurance premiums to emergency funds, our causes address the critical needs of sickle cell warriors with direct, measurable impact.
Our structured programs address every dimension of the sickle cell warrior's journey — from healthcare and nutrition to digital empowerment and psychosocial support.
Build a legacy through strategic philanthropy. Partner with OOSCF for measurable, transparent social impact.
Align your brand with one of Nigeria's most impactful sickle cell foundations. Flexible, visible, and deeply impactful partnership models for organisations of every size.
Join our exclusive giving community for individuals who want lasting, transformational impact on sickle cell warriors.
Support warriors with goods, services, or expertise — medicines, equipment, logistics, or professional services.
Real stories from real warriors — and the families, donors, and volunteers who stand with them.
Moments of courage, community, and compassion captured from our programs across Nigeria.